Stock Taper Q4 2025 Revenue: $71.9 million, up 116% year-over-year from $33.2 million.
Full Year 2025 Revenue: $235.2 million, a 110% increase from $111.9 million in 2024.
Adjusted Net Income: Q4 adjusted net income was $23 million, a 71% increase year-over-year; full year adjusted net income was $85.7 million, up 84% from $46.5 million.
Adjusted EBITDA: Q4 adjusted EBITDA reached $38.6 million (132% increase), with a margin of 54%. Full year adjusted EBITDA was $132.6 million (115% increase), maintaining a margin of 56%.
Capital Deployed: $230.7 million in Q4, an 82% increase year-over-year; total capital deployment for 2025 was $580.8 million.
Return on Equity (ROE) and Return on Invested Capital (ROIC): Both at 20% for 2025.
Market Leadership: ABX has established itself as a leader in the mortality-driven asset space, with a focus on life insurance policies that are uncorrelated to macroeconomic factors.
Data and Technology: The launch of Abacus Intel and the mVerify product has enhanced the company's data capabilities, providing accurate mortality verification and improving underwriting processes.
Acquisition of Manning & Napier: ABX has invested $50 million for a minority stake in Manning & Napier, which is expected to create synergies across wealth management, policy origination, and asset management.
Securitization Strategy: The company launched its first securitization in October 2025 and plans to increase the size of future securitizations based on strong demand.
2026 Guidance: ABX projects adjusted net income between $96 million and $104 million, implying growth of up to 22% compared to 2025.
Long-term Goals: By 2028, ABX aims for $250 million in EBITDA and $30 billion in total AUM, with recurring revenue expected to grow from 16% to 60% of total revenue in five years.
Market Perception: Despite strong financial performance, the company acknowledges a disconnect between its fundamentals and market valuation, which it views as a challenge to overcome.
Increased Competition: As the market for longevity-linked assets grows, competition may intensify, potentially impacting margins and market share.
Securitization Risks: While the initial securitization was successful, future performance will depend on continued investor demand and market conditions.
Securitization Demand: Management indicated strong demand for future securitizations, potentially larger than the initial $50 million offering, driven by market volatility.
Equity Issuance: There is no current intention to raise equity for policy purchases, as the company believes it can fund growth through organic capital generation.
Capital Deployment Strategy: Management emphasized a disciplined approach to capital deployment, focusing on maximizing returns and managing the timing of policy sales.
Growth Drivers: The company plans to leverage both organic growth and strategic acquisitions to achieve its ambitious growth targets, with a focus on enhancing asset management capabilities. Overall, ABX demonstrated robust financial growth in 2025, with a clear strategy for future expansion and an optimistic outlook, despite some challenges related to market perception and competition.
SOURCE: Q4 2025 EARNINGS CALL TRANSCRIPT